Clinical Trial

Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL

Study acronym: GENICa
Recruiting
View on ClinicalTrials.gov →
Summary
The project aims to retrospectively and prospectively analyze a population of CADASIL patients in order to study the natural history of the disease by correlating the symptom spectrum with genetic risk and specific neuroradiological and biological markers \- Stratifying patients according to their disease risk, this could contribute to the discovery of personalized therapeutic targets.
Trial Details
NCT Number NCT06938100
Lead Sponsor Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions CADASIL, CADASIL (Diagnosis)
Enrollment 100 participants
Start Date 2023-11-21
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-22